WallStreetZenWallStreetZen

NASDAQ: CJJD
China Jo Jo Drugstores Inc Stock

$2.22-0.13 (-5.53%)
Updated Jul 12, 2024
CJJD Price
$2.22
Fair Value Price
N/A
Market Cap
$3.74M
52 Week Low
$1.95
52 Week High
$9.18
P/E
-0.06x
P/B
0.2x
P/S
0.04x
PEG
N/A
Dividend Yield
N/A
Revenue
$154.66M
Earnings
-$21.47M
Gross Margin
21.5%
Operating Margin
-13.88%
Profit Margin
-13.9%
Debt to Equity
4.09
Operating Cash Flow
-$4M
Beta
0.75
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CJJD Overview

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.

Zen Score

Industry Average (19)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CJJD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CJJD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CJJD is good value based on its book value relative to its share price (0.2x), compared to the US Pharmaceutical Retailers industry average (0.75x)
P/B vs Industry Valuation
CJJD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CJJD due diligence checks available for Premium users.

Be the first to know about important CJJD news, forecast changes, insider trades & much more!

CJJD News

Valuation

CJJD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.06x
Industry
-1.82x
Market
32.2x

CJJD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.2x
Industry
0.75x
CJJD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CJJD's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
CJJD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
CJJD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$94.8M
Liabilities
$77.2M
Debt to equity
4.09
CJJD's short-term assets ($69.82M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CJJD's short-term assets ($69.82M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CJJD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CJJD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
CJJD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CJJD vs Pharmaceutical Retailer Stocks

TickerMarket Cap1d %P/EP/B
CJJD$3.74M-5.45%-0.06x0.20x
LFLY$5.32M+3.21%-0.71x-0.37x
SSY$5.72M+3.05%-0.78x0.49x
BIMI$15.88M0.00%-0.53x1.82x
MEDS$23.82M-8.03%-10.02x1.75x

China Jo Jo Drugstores Stock FAQ

What is China Jo Jo Drugstores's quote symbol?

(NASDAQ: CJJD) China Jo Jo Drugstores trades on the NASDAQ under the ticker symbol CJJD. China Jo Jo Drugstores stock quotes can also be displayed as NASDAQ: CJJD.

If you're new to stock investing, here's how to buy China Jo Jo Drugstores stock.

What is the 52 week high and low for China Jo Jo Drugstores (NASDAQ: CJJD)?

(NASDAQ: CJJD) China Jo Jo Drugstores's 52-week high was $9.18, and its 52-week low was $1.95. It is currently -75.82% from its 52-week high and 13.85% from its 52-week low.

How much is China Jo Jo Drugstores stock worth today?

(NASDAQ: CJJD) China Jo Jo Drugstores currently has 1,682,861 outstanding shares. With China Jo Jo Drugstores stock trading at $2.22 per share, the total value of China Jo Jo Drugstores stock (market capitalization) is $3.74M.

China Jo Jo Drugstores stock was originally listed at a price of $3.54 in Oct 1, 2009. If you had invested in China Jo Jo Drugstores stock at $3.54, your return over the last 14 years would have been -37.29%, for an annualized return of -3.28% (not including any dividends or dividend reinvestments).

How much is China Jo Jo Drugstores's stock price per share?

(NASDAQ: CJJD) China Jo Jo Drugstores stock price per share is $2.22 today (as of Jul 12, 2024).

What is China Jo Jo Drugstores's Market Cap?

(NASDAQ: CJJD) China Jo Jo Drugstores's market cap is $3.74M, as of Jul 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

China Jo Jo Drugstores's market cap is calculated by multiplying CJJD's current stock price of $2.22 by CJJD's total outstanding shares of 1,682,861.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.